China SFDA Puts 307 Drugs On Digital List To Track Route To Market
This article was originally published in PharmAsia News
Executive Summary
China's State FDA says it is placing 307 drugs considered essential on a national digital network by the end of the year so it can monitor them from production to market
|
China's State FDA says it is placing 307 drugs considered essential on a national digital network by the end of the year so it can monitor them from production to market. The agency estimated more than 3,500 companies making drugs in China would have a drug on the list. With the network list, the SFDA expects to be able to respond instantly to inquiries about inventories and destinations of the drugs by assigning each drug package its own code. The process is intended to enable tracking of a listed drug from manufacture through transportation, storage and sale. (Click here for more) "All Essential Drugs to Go On China's Digital Monitoring Network" - Xinhua (China) (8/3/10) |